AU Patent

AU2010261206B2 — Substituted isoquinoline derivative

Assigned to D Western Therapeutics Institute Inc · Expires 2015-10-08 · 11y expired

What this patent protects

Disclosed is an isoquinoline-6-sulfonamide derivative which is useful as a novel medicinal agent. Specifically disclosed is an isoquinoline-6-sulfonamide derivative represented by general formula (1) (wherein X and Y independently represent a direct bond, NH, CH=CH, O or S; R

USPTO Abstract

Disclosed is an isoquinoline-6-sulfonamide derivative which is useful as a novel medicinal agent. Specifically disclosed is an isoquinoline-6-sulfonamide derivative represented by general formula (1) (wherein X and Y independently represent a direct bond, NH, CH=CH, O or S; R

Drugs covered by this patent

Patent Metadata

Patent number
AU2010261206B2
Jurisdiction
AU
Classification
—
Expires
2015-10-08
Drug substance claim
No
Drug product claim
No
Assignee
D Western Therapeutics Institute Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.